Capricor Therapeutics
CAPR
#5534
Rank
โ‚ฌ1.13 B
Marketcap
20,85ย โ‚ฌ
Share price
7.34%
Change (1 day)
54.22%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ0.08 M-99.94%
2025โ‚ฌ0.15 B154.62%
2024โ‚ฌ61.89 M1584.06%
2023โ‚ฌ3.67 M24.67%
2022โ‚ฌ2.94 M-49.93%
2021โ‚ฌ5.88 M-88.57%
2020โ‚ฌ51.49 M573.14%
2019โ‚ฌ7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
โ‚ฌ24.94 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ5.02 Mโ‚ฌ30.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ3.61 Mโ‚ฌ34.11 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ6.56 Mโ‚ฌ10.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ0.78 Mโ‚ฌ0.84 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/Aโ‚ฌ1.49 M๐Ÿ‡บ๐Ÿ‡ธ USA